BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Straalen KR, Schneider-Burrus S, Prens EP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol 2020;183:e178-87. [PMID: 29981245 DOI: 10.1111/bjd.16768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Willems D, Hiligsmann M, van der Zee HH, Sayed CJ, Evers SMAA. Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study. Patient 2021. [PMID: 34368925 DOI: 10.1007/s40271-021-00539-7] [Reference Citation Analysis]
2 van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021;85:369-78. [PMID: 33484766 DOI: 10.1016/j.jaad.2020.12.089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Current and emerging treatments. J Am Acad Dermatol 2020;82:1061-82. [PMID: 31604100 DOI: 10.1016/j.jaad.2019.08.089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
4 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Howells L, Lancaster N, McPhee M, Bundy C, Ingram JR, Leighton P, Henaghan-Sykes K, Thomas KS. Thematic synthesis of the experiences of people with hidradenitis suppurativa: a systematic review. Br J Dermatol 2021. [PMID: 34050935 DOI: 10.1111/bjd.20523] [Reference Citation Analysis]
6 Frew JW, Navrazhina K, Marohn M, Lu PC, Krueger JG. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa. Exp Dermatol 2019;28:886-91. [PMID: 31140657 DOI: 10.1111/exd.13978] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
7 Shavit E, Pawliwec A, Alavi A, George R. The surgeon’s perspective: a retrospective study of wide local excisions taken to healthy subcutaneous fat in the management of advanced hidradenitis suppurativa. Can J Surg 2020;63:E94-9. [PMID: 32109015 DOI: 10.1503/cjs.003119] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Front Immunol. 2018;9:2965. [PMID: 30619323 DOI: 10.3389/fimmu.2018.02965] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 18.3] [Reference Citation Analysis]